PYCR2 Mutation Causing Hypomyelination and Microcephaly in an Indian Child

Preeti Srivastava1, Asit Kumar Mishra1, Nilanjan Sarkar2

  • 1Pediatrics, Tata Main Hospital, Jamshedpur, IND.

Cureus
|May 31, 2021
PubMed

Insights

Hypomyelinating leukodystrophy (HLD) is a group of genetic disorders affecting myelin formation in the central nervous system. This case highlights a PYCR2 gene mutation causing HLD-10 in a child with developmental delay and microcephaly.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Hypomyelinating leukodystrophy (HLD) comprises genetically diverse disorders characterized by impaired myelin sheath formation in the central nervous system (CNS).
  • Clinical presentations often include motor dysfunction, cognitive impairment, and specific MRI findings indicating white matter abnormalities.

Observation:

  • A three-year-old boy presented with global developmental delay, dysmorphic features, motor signs, progressive microcephaly, and failure to thrive.
  • Initial investigations and metabolic tests were unremarkable.
  • Brain MRI revealed hypomyelination, cerebral atrophy, and corpus callosum thinning, with normal cerebellum, brainstem, and deep grey nuclei.

Findings:

  • Clinical exome sequencing identified compound heterozygous mutations in the PYCR2 gene.
  • The identified genotype correlated with the patient's clinical phenotype, leading to a diagnosis of hypomyelinating leukodystrophy-10 (HLD-10).

Implications:

  • Genetic testing is crucial for diagnosing complex neurological disorders with overlapping symptoms.
  • Accurate diagnosis of HLD-10 aids in predicting disease course, potential treatments, and prognosis.
  • Understanding the genetic basis of HLD is vital for genetic counseling and family planning.

Related Concept Videos